Advaxis, Inc. Announces Closing of $9.2 Million Public Offering
PRINCETON, N.J., Nov. 27, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS) (the “Company”), a clinical-stage biotechnology company focused on...
PRINCETON, N.J., Nov. 27, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS) (the “Company”), a clinical-stage biotechnology company focused on...
Correction of the press release published November 27, 2020. The release contained incorrect dates within the financial table. This has...
All Figures Are Stated in United States Dollars ($) Unless Otherwise Indicated LAS VEGAS, NV / ACCESSWIRE / November 27,...
TORONTO, ON / ACCESSWIRE / November 27, 2020 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical-stage pharmaceutical...
CORNWALL, ON / ACCESSWIRE / November 27, 2020 / In an effort to help patients live happier, healthier and better...
Leafbuyer Turns Black Friday Green with Cannabis Deals Event DENVER, CO / ACCESSWIRE / November 27, 2020 / Leafbuyer Technologies,...
Live demonstration now scheduled for 11:30am EST on Thursday, December 3 Company to host investor webinar following the live demonstration...
MALVERN, Pa., Nov. 27, 2020 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and...
Future References to Lead Drug Candidate for Alzheimer’s Disease Will Be Simufilam AUSTIN, Texas, Nov. 27, 2020 (GLOBE NEWSWIRE) --...
– R&D activities focused on advancing the development of innovative delivery systems and yeast beta glucan as a potential inhalable...
TORONTO, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic...
FLORHAM PARK, N.J., Nov. 27, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused...
Initial funding of up to $34 million for the project “Gene Mabs: A Scalable, Economic, Gene-Encoded Protective Antibody Platform Against...
Biogen and Sage enter into an agreement to jointly develop and commercialize zuranolone and SAGE-324 in the U.S. Biogen to...
IMCIVREE™(setmelanotide) Logo Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™(setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity...
Company announcement, Inside information, Helsinki, 27 November 2020 at 14.00 (EET) Nexstim Plc provides an update on the pilot study...
Approval by MHLW provides new HIF-PH inhibitor treatment option for healthcare providers and adult patients with anemia of CKD not...
KINGSTON, Ontario, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Today, renowned public policy experts Don Drummond and Duncan Sinclair released a...
TORONTO, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Braingrid Limited (CSE: BGRD) (“Braingrid” or the “Company”) is pleased to announce that...
VANCOUVER, British Columbia, Nov. 26, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”) is...